Viz.ai has announced the appointment of Tim Showalter, MD, MPH, MBA, as its first Chief Medical Officer, marking a key step in strengthening its clinical leadership as the company expands its artificial intelligence-based care coordination platform. Dr. Showalter will lead Viz.ai’s clinical strategy and report to Chris Mansi, MD, CEO and Co-Founder.
Commenting on the appointment, Mansi said, “Tim’s unique combination of clinical excellence, deep AI and oncology experience, and proven success in translating innovation into clinical impact make him the perfect clinician to deliver on the broad applicability of the Viz.ai Platform.” He added that as Viz.ai broadens its reach into oncology, pulmonology, and other specialties, Showalter’s leadership will support stronger clinical and financial outcomes.
Dr. Showalter brings more than 15 years of experience in oncology diagnostics, academic medicine, and AI-driven health technology. Most recently, he served as Chief Medical Officer at Artera AI, where he supported the development of AI-based biomarkers and the first digital pathology AI test to receive FDA clearance. He previously founded Advaray, a radiation therapy device company later acquired by CQ Medical. “I am honored to join Viz.ai at this inflection point for its growth,” Showalter said. “I look forward to building on that foundation to bring data-driven solutions to more diseases and better support clinicians.”